Abbott's Libre Duo 10 Day gains FDA approval, pioneers dual glucose and ketone monitoring in wearable device
Abbott Laboratories has received FDA clearance for its new Libre Duo 10 Day wearable device, the first in the US to continuously monitor both glucose and ketone levels, potentially transforming diabetes management and risk detection. Abbott Laboratories has won US…













